litlas
ログインアカウント作成

David W. Dodick

1995–2025 年に発表

263
論文数
36,378
被引用数
105
h 指数
243
i10 指数

被引用数

David W. Dodick の年別被引用数1993 年: 被引用 1 件1994 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 4 件1998 年: 被引用 2 件1999 年: 被引用 4 件2000 年: 被引用 8 件2001 年: 被引用 9 件2002 年: 被引用 18 件2003 年: 被引用 13 件2004 年: 被引用 24 件2005 年: 被引用 43 件2006 年: 被引用 59 件2007 年: 被引用 84 件2008 年: 被引用 91 件2009 年: 被引用 133 件2010 年: 被引用 149 件2011 年: 被引用 145 件2012 年: 被引用 138 件2013 年: 被引用 197 件2014 年: 被引用 156 件2015 年: 被引用 227 件2016 年: 被引用 216 件2017 年: 被引用 282 件2018 年: 被引用 300 件2019 年: 被引用 1,262 件2020 年: 被引用 1,378 件2021 年: 被引用 1,450 件2022 年: 被引用 1,224 件2023 年: 被引用 1,074 件2024 年: 被引用 1,717 件2025 年: 被引用 759 件2026 年: 被引用 17 件1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,466 件、この内訳の 27.9%イギリス: 引用元論文 685 件、この内訳の 7.8%イタリア: 引用元論文 579 件、この内訳の 6.6%ドイツ: 引用元論文 532 件、この内訳の 6%中国: 引用元論文 461 件、この内訳の 5.2%デンマーク: 引用元論文 398 件、この内訳の 4.5%スペイン: 引用元論文 305 件、この内訳の 3.4%オランダ: 引用元論文 245 件、この内訳の 2.8%カナダ: 引用元論文 244 件、この内訳の 2.8%フランス: 引用元論文 184 件、この内訳の 2.1%オーストラリア: 引用元論文 168 件、この内訳の 1.9%日本: 引用元論文 159 件、この内訳の 1.8%
0%27.9%その他 27.2%

機関

分野

  • Medicine88.2%
  • Neuroscience6.7%
  • Biochemistry, Genetics and Molecular Biology1.5%
  • Health Professions0.6%
  • Psychology0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • その他2%

トピック

  • Migraine and Headache Studies21.9%
  • Trigeminal Neuralgia and Treatments5.2%
  • Neurological Complications and Syndromes4.8%
  • Traumatic Brain Injury Research4.5%
  • Sympathectomy and Hyperhidrosis Treatments2.5%
  • Pain Mechanisms and Treatments2.5%
  • その他58.6%

共著者

全論文

検索で開く
  1. Migraine

    著者: Michel D. Ferrari, Peter J. Goadsby, Rami Burstein, Tobias Kurth, Cenk Ayata, Andrew Charles, Messoud Ashina, Arn M. J. M. van den Maagdenberg, David W. Dodick - Nature Reviews Disease Primers 2022 被引用: 522

  2. Fremanezumab for the Preventive Treatment of Chronic Migraine

    著者: Stephen D. Silberstein, David W. Dodick, Marcelo E. Bigal, Paul Yeung, Peter J. Goadsby, Tricia Blankenbiller, Melissa Grozinski‐Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi - New England Journal of Medicine 2017 被引用: 803

  3. Migraine

    著者: David W. Dodick - The Lancet 2018 被引用: 559

  4. ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

    著者: David W. Dodick, Messoud Ashina, Jan Lewis Brandes, David Kudrow, Michel Lantéri‐Minet, V. В. Osipova, Kerry Palmer, Hernàn Picard, Daniel D. Mikol, Robert Lenz - Cephalalgia 2018 被引用: 590

  5. Evaluation of Galcanezumab for the Prevention of Episodic Migraine

    著者: Virginia L. Stauffer, David W. Dodick, Qi Zhang, Jeffrey N. Carter, Jessica Ailani, Robert R. Conley - JAMA Neurology 2018 被引用: 566

  6. Ubrogepant for the Treatment of Migraine

    著者: David W. Dodick, Richard B. Lipton, Jessica Ailani, Kaifeng Lu, Michelle Finnegan, Joel M. Trugman, Armin Szegedi - New England Journal of Medicine 2019 被引用: 347

  7. National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome

    著者: Douglas I. Katz, Charles Bernick, David W. Dodick, Jesse Mez, Megan Mariani, Charles H. Adler, Michael L. Alosco, Laura J. Balcer, Sarah J. Banks, William Barr, David L. Brody, Robert C. Cantu, Kristen Dams-O’Connor, Yonas E. Geda, Barry D. Jordan, Thomas W. McAllister, Elaine R. Peskind, Ronald Petersen, Jennifer V. Wethe, Ross Zafonte, Éimear M. Foley, Debra Babcock, Walter J. Koroshetz, Yorghos Tripodis, Ann C. McKee, Martha E. Shenton, Jeffrey L. Cummings, Eric M. Reiman, Robert A. Stern - Neurology 2021 被引用: 326

  8. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

    著者: David W. Dodick, Stephen D. Silberstein, Marcelo E. Bigal, Paul Yeung, Peter J. Goadsby, Tricia Blankenbiller, Melissa Grozinski‐Wolff, Ronghua Yang, Yuju Ma, Ernesto Aycardi - JAMA 2018 被引用: 573

  9. Global synergistic actions to improve brain health for human development

    著者: Mayowa Owolabi, Matilde Leonardi, Claudio L. Bassetti, Joke Jaarsma, Tadeusz Hawrot, Akintomiwa Makanjuola, Rajinder K. Dhamija, Wuwei Feng, Volker Straub, Jennifer Camaradou, David W. Dodick, Rosita Sunna, Bindu Menon, Claire Wright, Chris Lynch, Antonella Santuccione Chadha, Maria Teresa Ferretti, Anna Dé, Coriene E. Catsman‐Berrevoets, Muthoni Gichu, Cristina Tassorelli, David Oliver, Walter Paulus, Ramla K. Mohammed, Augustina Charway‐Felli, Kevin Rostásy, Valery L. Feigin, Audrey Craven, Elizabeth Cunningham, Orla Galvin, Alexandra Heumber Perry, Ericka L. Fink, Peer Baneke, Anne Helme, Joanna Laurson-Doube, Marco T. Medina, Juan David Roa, Birgit Högl, Allan O’Bryan, Claudia Trenkwalder, Jo M. Wilmshurst, Rufus Akinyemi, Joseph Yaria, David C. Good, Volker Hoemberg, Paul Boon, Samuel Wiebe, J. Helen Cross, Magali Haas, Inez Jabalpurwala, Marijeta Mojasevic, Mónica Di Luca, Paola Barbarino, Stéphanie Clarke, Sameer M. Zuberi, Paul Olowoyo, Ayomide Owolabi, Nelson M. Oyesiku, Pia C. Sundgren, Bo Norrving, Surjo R. Soekadar, Pieter A. van Doorn, Richard Lewis, Tom Solomon, Franco Servadei - Nature Reviews Neurology 2023 被引用: 113

  10. A Phase‐by‐Phase Review of Migraine Pathophysiology

    著者: David W. Dodick - Headache The Journal of Head and Face Pain 2018 被引用: 497

  11. Migraine: integrated approaches to clinical management and emerging treatments

    著者: Messoud Ashina, Dawn C. Buse, Håkan Ashina, Patricia Pozo‐Rosich, Mário Fernando Prieto Peres, Mi Ji Lee, Gisela M. Terwindt, Rashmi B. Halker Singh, Cristina Tassorelli, Thien Phu, Dimos D. Mitsikostas, David W. Dodick - The Lancet 2021 被引用: 296

  12. Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial

    著者: Peter J. Goadsby, David W. Dodick, Jessica Ailani, Joel M. Trugman, Michelle Finnegan, Kaifeng Lu, Armin Szegedi - The Lancet Neurology 2020 被引用: 230

  13. Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine

    著者: Richard B. Lipton, David W. Dodick, Jessica Ailani, Kaifeng Lu, Michelle Finnegan, Armin Szegedi, Joel M. Trugman - JAMA 2019 被引用: 276

  14. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study

    著者: Dawn C. Buse, Michael L. Reed, Kristina M. Fanning, Ryan Bostic, David W. Dodick, Todd J. Schwedt, Sagar Munjal, Preeti Singh, Richard B. Lipton - The Journal of Headache and Pain 2020 被引用: 307

  15. Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA

    著者: David W. Dodick, Peter J. Goadsby, Todd J. Schwedt, Richard B. Lipton, Chengcheng Liu, Kaifeng Lu, Sung Yun Yu, Lawrence Severt, Michelle Finnegan, Joel M. Trugman - The Lancet 2023 被引用: 85

  16. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults

    著者: Cristina Tassorelli, Hans‐Christoph Diener, David W. Dodick, Stephen D. Silberstein, Richard B. Lipton, Messoud Ashina, Werner J. Becker, Michel D. Ferrari, Peter J. Goadsby, Patricia Pozo‐Rosich, Shuu‐Jiun Wang - Cephalalgia 2018 被引用: 385

  17. OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

    著者: David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans‐Christoph Diener, Mitchell F. Brin - Headache The Journal of Head and Face Pain 2010 被引用: 986

  18. Adherence to oral migraine-preventive medications among patients with chronic migraine

    著者: Zsolt Hepp, David W. Dodick, Sepideh F. Varon, Patrick Gillard, Ryan N. Hansen, Emily Beth Devine - Cephalalgia 2014 被引用: 434

  19. Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults

    著者: Stephen D. Silberstein, Starr Holland, F. G. Freitag, David W. Dodick, Charles E. Argoff, Eric Ashman - Neurology 2012 被引用: 889

  20. Migraine and risk of stroke

    著者: Lise Rystad Øie, Tobias Kurth, Sasha Gulati, David W. Dodick - Journal of Neurology Neurosurgery & Psychiatry 2020 被引用: 219

  21. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis

    著者: Zsolt Hepp, David W. Dodick, Sepideh F. Varon, Jenny Chia, Nitya Matthew, Patrick Gillard, Ryan N. Hansen, Emily Beth Devine - Cephalalgia 2016 被引用: 361

  22. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults

    著者: Hans‐Christoph Diener, Cristina Tassorelli, David W. Dodick, Stephen D. Silberstein, Richard B. Lipton, Messoud Ashina, Werner J. Becker, Michel D. Ferrari, Peter J. Goadsby, Patricia Pozo‐Rosich, Shuu‐Jiun Wang, Timothy T. Houle, Thomas C. van den Hoek, Daniele Martinelli, Gisela M. Terwindt - Cephalalgia 2020 被引用: 216

  23. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences

    著者: Richard B. Lipton, Sagar Munjal, Aftab Alam, Dawn C. Buse, Kristina M. Fanning, Michael L. Reed, Todd J. Schwedt, David W. Dodick - Headache The Journal of Head and Face Pain 2018 被引用: 188

  24. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace

    著者: Toshihiko Shimizu, Fumihiko Sakai, Hitoshi MIYAKE, Tomofumi Sone, Mitsuhiro Sato, Satoshi Tanabe, Yasuhiro Azuma, David W. Dodick - The Journal of Headache and Pain 2021 被引用: 207